Loading...
Market
Which countries will approve the new brain implant technology for Parkinson's disease by December 31, 2025?
2
Resolution / Starting Odds
USA • 25%
EU • 25%
Japan • 25%
Other • 25%
Official announcements from respective health regulatory authorities
Story
New Brain Implant Reduces Parkinson's Symptoms by 50% in Early Trials
Aug 19, 2024, 07:14 PM
Recent studies have shown promising results for a new brain implant technology aimed at alleviating symptoms of Parkinson's disease. This innovative approach involves an intelligent pacemaker that offers deep brain stimulation, providing personalized neuromodulation tailored to individual needs. The device, guided by artificial intelligence, has been shown to reduce Parkinson's symptoms by 50 percent in early trials. Experts suggest that the implant could offer around-the-clock care, adapting to the brain's activity to deliver more effective and long-term relief. This technology represents a significant advancement over current techniques, potentially improving movement and sleep for those affected by Parkinson's.
View original story
Similar markets
United States • 25%
European Union • 25%
China • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
Switzerland • 25%
Germany • 25%
France • 25%
Other • 25%
UK • 25%
US • 25%
EU • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
0-5 countries • 25%
6-10 countries • 25%
11-20 countries • 25%
More than 20 countries • 25%
Significant improvement • 25%
Moderate improvement • 25%
No significant improvement • 25%
Worsening of symptoms • 25%
Yes • 50%
No • 50%
0-5 countries • 25%
6-10 countries • 25%
11-20 countries • 25%
More than 20 countries • 25%